Literature DB >> 24346059

Cannabinoid CB2 receptor immunolabelling in the healthy brain--still a live possibility.

John C Ashton1, Yiwen Zheng, Cynthia Darlington, Jean-Ha Baek, Paul F Smith.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24346059     DOI： 10.1007/s00210-013-0948-y

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN： 0028-1298            Impact factor:   3.000


× No keyword cloud information.
  2 in total

1.  Antibody testing for brain immunohistochemistry: brain immunolabeling for the cannabinoid CB₂ receptor.

Authors:  Jean-Ha Baek; Cynthia L Darlington; Paul F Smith; John C Ashton
Journal:  J Neurosci Methods       Date:  2013-04-09       Impact factor: 2.390

2.  Evaluation of the specificity of antibodies raised against cannabinoid receptor type 2 in the mouse retina.

Authors:  Bruno Cécyre; Sébastien Thomas; Maurice Ptito; Christian Casanova; Jean-François Bouchard
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2013-11-05       Impact factor: 3.000
  2 in total
  3 in total

1.  Neuronal expression of CB2 cannabinoid receptor mRNAs in the mouse hippocampus.

Authors:  Y Li; J Kim
Journal:  Neuroscience       Date:  2015-10-26       Impact factor: 3.590

2.  Naunyn-Schmiedeberg's Archives of Pharmacology under new editorship: change and continuity.

Authors:  Roland Seifert
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2016-05-24       Impact factor: 3.000

Review 3.  Progress in brain cannabinoid CB2 receptor research: From genes to behavior.

Authors:  Chloe J Jordan; Zheng-Xiong Xi
Journal:  Neurosci Biobehav Rev       Date:  2019-01-03       Impact factor: 8.989
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.